Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

NCT01922375 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

411

Enrollment

INDUSTRY

Sponsor class

Conditions

Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Interventions

DRUG: Naftopidil

Sponsor

Dong-A Pharmaceutical Co., Ltd.